Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer
Renata Huzjan, Evis Sala and Hedvig Hricak*
Correspondence *Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Email hricakh@mskcc.org
In this review, Renata Huzjan and colleagues discuss the utility of MRI and magnetic resonance spectroscopic imaging (MRSI) in the diagnosis and management of prostate cancer. MRI and MRSI provide important information on the extent, location and characteristics of tumors that is invaluable in pretreatment decision making. In order to fully exploit these techniques, a multidisciplinary approach is essential.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
High-intensity focused ultrasound therapy for clinically localized prostate cancerProstate Cancer and Prostatic Diseases Original Article
See all 4 matches for Research